| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 6. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | lopinavir/ritonavir (Kaletra®) |
| Formulation | 100 mg/25 mg film-coated tablet |
| Reference number | 190 |
| Indication | Treatment of HIV-1 infected adults and children above the age of 2 years, in combination with other antiretroviral agents |
| Company | AbbVie Ltd |
| BNF chapter | Infections |
| Assessment type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 21/02/2008 |